Vanessa McDade

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC.

Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US.

Spring Discovery, Inc. provides machine learning-based drug discovery platform. It built a machine learning platform to accelerate experimentation for discovering therapies for aging and its related diseases. The company was founded by Ben Kamens and is headquartered in Paolo Alto, California.

Oryn Therapeutics LLC develops and commercializes therapeutics. The private company is based in Vacaville.

LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA.

AdhereTech LLC provides prescription drug packaging solutions. The firm develops smart pill bottle that enables to know when pills and liquid medication is missed by patients. The company was founded by Josh Stein and is headquartered in New York, NY.

Part of Fresenius Medical Care AG, Excorim is a Swedish company that provides medical immunology research. The company is based in Lund, Sweden. Excorim was acquired by Fresenius Hemocare from Gambro AB on December 14, 1999.

Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.

Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.

The Tectonic Theater Project, Inc. is a theater company founded by Moises Kaufman. The non-profit company is based in New York, NY. The company's work includes the critically acclaimed play "Here There Are Blueberries," which is based on true events surrounding a mysterious album of never-before-seen Nazi-era photographs that arrived at the desk of Holocaust Memorial Museum archivist Rebecca Erbelding. The play was conceived and directed by Moises Kaufman and written by Kaufman and Gronich. The company has upcoming plans for new projects and offers opportunities for support.

Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001.

Part of Versant Venture Management LLC, Highline Therapeutics, Inc. operates as a biotech incubator. The company is based in New York, NY.

Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY.

The English Concert in America, Inc. engages in promoting appreciation of baroque chamber music. It provides opportunities for audiences and assisting with the education and development. The company was founded by Trevor Pinnock in 1973 and is headquartered in London, The United Kingdom.

Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY.

The Knights is an orchestral collective that is flexible in size and repertory. The private company is based in Brooklyn. The American company is on a quest to expand the boundaries of classical music and imagine new possibilities for the art form as they explore a wide universe of music. The company offers performances, partnerships, and collaborations in education. The Knights also have a patron program and an innovation fund. The company's support inspires them, sustains them, and helps make possible the incredible adventures ahead.

TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

One Planet VC LLC (One Planet VC) is a venture capital firm subsidiary of One Planet Group Inc founded in 2015 by Payam Zamani. The firm is headquartered in Walnut creek, California.

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation.

Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC.